Handok, Inc. (002390) Price & Analysis

― Followers

002390 Stock Chart & Stats

₩8860.00

₩180.00(2.07%)

Jul 30, 2026

―

Day’s Range― - ―

52-Week Range₩6,460.00 - ₩12,900.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)23.30K

Market Cap

₩120.43B

Enterprise ValueN/A

Total Cash (Recent Filing)₩24.14B

Total Debt (Recent Filing)₩378.43B

Price to Earnings (P/E)―

Beta0.01

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-262.10

Shares Outstanding13,763,533

10 Day Avg. Volume35,652

30 Day Avg. Volume23,299

Financial Highlights & Ratios

PEG Ratio0.72

Price to Book (P/B)0.56

Price to Sales (P/S)0.29

P/FCF Ratio-15.60

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)2,302,496.33

Revenue Forecast (FY)₩10.00T>

002390 FAQ

What was Handok, Inc.’s price range in the past 12 months?

Handok, Inc. lowest stock price was ₩6460.00 and its highest was ₩12900.00 in the past 12 months.

What is Handok, Inc.’s market cap?

Handok, Inc.’s market cap is ₩120.43B.

When is Handok, Inc.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Handok, Inc.’s earnings last quarter?

Handok, Inc. released its earnings results on May 14, 2026. The company reported -₩657.956 earnings per share for the quarter, missing the consensus estimate of N/A by -₩657.956.

Is Handok, Inc. overvalued?

According to Wall Street analysts Handok, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Handok, Inc. pay dividends?

Handok, Inc. does not currently pay dividends.

What is Handok, Inc.’s EPS estimate?

Handok, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Handok, Inc. have?

Handok, Inc. has 13,763,533 shares outstanding.

What happened to Handok, Inc.’s price movement after its last earnings report?

Handok, Inc. reported an EPS of -₩657.956 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.262%.

Which hedge fund is a major shareholder of Handok, Inc.?

Currently, no hedge funds are holding shares in KR:002390

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Handok, Inc.

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products. In addition, the company engages in real estate leasing. The company was formerly known as Handok Pharmaceuticals Co., Ltd and changed its name to Handok Inc. in July 2013. Handok Inc. was founded in 1954 and is headquartered in Seoul, South Korea.